Abstract:Deamidation has been recognized as a common spontaneous pathway of protein degradation and a prevalent concern in the pharmaceutical industry; deamidation caused the reduction of protein/peptide drug efficacy and shelf life in several cases. More importantly, deamidation of physiological proteins is related to several human diseases and considered a "timer" for the diseases. N-linked glycosylation has a variety of significant biological functions, and it interestingly occurs right on the deamidation site—asparagine. It has been perceived that N-glycosylation could prevent deamidation, but experimental support is still lacking for clearly understanding the role of N-glycosylation on deamidation. Our results presented that deamidation is prevented by naturally occurring N-linked glycosylation. Glycopeptides and corresponding nonglycosylated peptides were used to compare their deamidation rates. All the nonglycosylated peptides have different half-lives ranging from one to 20 days, for the corresponding glycosylated peptides; all the results showed that the deamidation reaction was significantly reduced by the introduction of N-linked glycosylation. A glycoprotein, RNase B, also showed a significantly elongated deamidation half-life compared to nonglycosylated protein RNase A. At last, N-linked glycosylation on INGAP-P, a therapeutic peptide, increased the deamidation half-life of INGAP-P as well as its therapeutic potency.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acschembio.0c00734?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acschembio.0c00734</a>.Details of experimental procedures, HPLC results, plots of half-life calculation, and peptide characterization (<a class="ext-link" href="/doi/suppl/10.1021/acschembio.0c00734/suppl_file/cb0c00734_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Synthesis of PNGase-resistant N-glycopeptide Containing an Α-Anomeric Glycosidic Linkage

A Novel Enzymatic Method for Synthesis of Glycopeptides Carrying Natural Eukaryotic N-Glycans

Discovery of Highly Active Recombinant PNGase H+ Variants Through the Rational Exploration of Unstudied Acidobacterial Genomes

Releasing N-glycan from Peptide N-terminus by N-terminal Succinylation Assisted Enzymatic Deglycosylation

Discovery and Characterization of a Novel Extremely Acidic Bacterial N-glycanase with Combined Advantages of PNGase F and A

Research Progress of The Peptide??N-Glycanase (PNGase) br

Engineered yeast with PNGase F on cell surface for releasing of N-glycans from glycoproteins

Direct Formation of Amide-Linked C-Glycosyl Amino Acids and Peptides via Photoredox/Nickel Dual Catalysis

Site-Directed Glycosylation of Peptide/Protein with Homogeneous O-Linked Eukaryotic N-Glycans

Highly Efficient Production of Peptides: N-glycosidase F for N-glycomics Analysis.

Late-stage C(sp2)-H and C(sp3)-H Glycosylation of C-aryl/alkyl Glycopeptides: Mechanistic Insights and Fluorescence Labeling.

A Peptide N-Terminal Protection Strategy For Comprehensive Glycoproteome Analysis Using Hydrazide Chemistry Based Method

Exploiting Complex-Type N-Glycan to Improve the in Vivo Stability of Bioactive Peptides

Synthesis of lipid-linked oligosaccharides by a compartmentalized multi-enzyme cascade for the in vitro N-glycosylation of peptides

An Advance in the Chemical Synthesis of Homogeneous N‐Linked Glycopolypeptides by Convergent Aspartylation

Synthesis of and Specific Antibody Generation for Glycopeptides with Arginine N-GlcNAcylation.

Chemical and Chemoenzymatic Synthesis of Peptide and Protein Therapeutics Conjugated with Human N‐Glycans

Synthesis Of Biologically Active N- And O-Linked Glycans With Multisialylated Poly-N-Acetyllactosamine Extensions Using P. Damsela Alpha 2-6 Sialyltransferase

N-Linked Glycosylation Prevents Deamidation of Glycopeptide and Glycoprotein

A toolbox of diverse arginine N-glycosylated peptides and specific antibodies

Pngases As Valuable Tools In Glycoprotein Analysis